Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Globus Medical (GMED)
NYSE:GMED
Holding GMED?
Track your performance easily
Globus Medical (GMED) Ownership Overview
16.45% Insiders
30.69% Mutual Funds
0.69% Other Institutional Investors
21.08% ETFs
31.09% Public Companies and Individual Investors
The ownership structure of Globus Medical (GMED) stock is a mix of institutional, retail, and individual investors. Approximately 52.46% of the company’s stock is owned by Institutional Investors, 16.45% is owned by Insiders, and 31.09% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 25, 2024 | Dan Lemaitre Director | xxxxxxxxxxxxx | $1221886 |
| Sep 17, 2024 | David Davidar Director | xxxxxxxxxxxxx | $1761500 |
| Sep 17, 2024 | Ann Rhoads Director | xxxxxxxxxxxxx | $1055400 |
| May 14, 2024 | Dan Lemaitre Director | xxxxxxxxxxxxx | $4089813 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $1645 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $2350303 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $2791776 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $3306936 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 21,304,758 | Insider | 15.76% | 1,931,276,313 | |
| 10,341,757 | Institution | 9.09% | 937,480,272 | |
| 9,635,925 | Institution | 8.47% | 873,496,601 | |
| 8,886,835 | Institution | 7.81% | 805,591,593 | |
| 5,414,491 | Institution | 4.76% | 490,823,609 | |
| 1,934,960 | Institution | 1.70% | 175,404,124 | |
| 1,928,332 | Institution | 1.70% | 174,803,296 | |
| 1,666,175 | Institution | 1.46% | 151,038,764 | |
| 1,114,591 | Institution | 0.98% | 101,037,674 | |
| 1,074,070 | Institution | 0.94% | 97,364,446 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,635,925 | Institution | 8.47% | 873,496,601 | |
| 5,414,491 | Institution | 4.76% | 490,823,609 | |
| 1,928,332 | Institution | 1.70% | 174,803,296 | |
| 1,666,175 | Institution | 1.46% | 151,038,764 | |
| 1,114,591 | Institution | 0.98% | 101,037,674 | |
| 967,783 | Institution | 0.85% | 87,729,529 | |
| 748,430 | Institution | 0.66% | 67,845,180 | |
| 687,226 | Institution | 0.60% | 62,297,037 | |
| 665,000 | Institution | 0.58% | 60,282,250 | |
| 628,700 | Institution | 0.55% | 56,991,655 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,688,672 | Institution | 3.24% | 334,378,117 | |
| 3,535,241 | Institution | 3.11% | 302,651,982 | |
| 2,849,270 | Institution | 2.51% | 243,926,005 | |
| 2,428,038 | Institution | 2.13% | 126,889,266 | |
| 1,692,266 | Institution | 1.49% | 144,874,892 | |
| 1,567,646 | Institution | 1.38% | 134,206,174 | |
| 921,699 | Institution | 0.81% | 83,552,014 | |
| 711,751 | Institution | 0.63% | 64,520,228 | |
| 617,969 | Institution | 0.54% | 56,018,890 | |
| 551,737 | Institution | 0.49% | 48,652,169 |
FAQ
Who Owns Globus Medical (GMED)?
According to the latest TipRanks data, approximately 0.69% of the company's stock is held by institutional investors, 16.45% is held by insiders, and 31.09% is held by retail investors.
What percentage of Globus Medical (GMED) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.69% of Globus Medical (GMED) stock is held by institutional investors.
What percentage of Globus Medical (GMED) stock is held by retail investors?
According to the latest TipRanks data, approximately 31.09% of Globus Medical (GMED) stock is held by retail investors.
Who owns the most shares of Globus Medical (GMED)?
David C. Paul owns the most shares of Globus Medical (GMED).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.